Epredia

Epredia was established in July 2019 through PHC Group's acquisition from Thermo Fisher Scientific. Backed by trusted brands such as Richard-Allan Scientific, Microm, Shandon, MenzelGläser, and Erie Scientific, Epredia offers a wide range of solutions that have transformed and will continue to transform the anatomical pathology market.Epredia is a global precision cancer diagnostics company dedicated to improving patient outcomes by providing breakthrough technologies.